Jeffrey L Cleland

Title: Innovations by Jeffrey L. Cleland

Introduction

Jeffrey L. Cleland is an accomplished inventor based in Redwood City, CA. He has made significant contributions to the field of drug delivery and treatment methods, particularly focusing on dendrimer compositions. With a total of 3 patents, his work is paving the way for advancements in medical therapies.

Latest Patents

One of his latest patents involves dendrimer compositions and methods for drug delivery to the eye. This innovation includes hydroxyl-terminated dendrimers complexed or conjugated with active agents aimed at treating inflammatory and angiogenic diseases of the eye. The compositions are designed for systemic administration to target activated microglia and macrophages in the retina and choroid. Another notable patent focuses on methods for treating severe inflammation. This method involves administering dendrimers complexed with therapeutic agents to alleviate symptoms of severe inflammation in the lungs, particularly in cases of acute lung injury and respiratory distress syndrome.

Career Highlights

Jeffrey L. Cleland is currently associated with Ashvattha Therapeutics, Inc., where he continues to develop innovative solutions in the medical field. His expertise in dendrimer technology has positioned him as a key player in advancing therapeutic methods.

Collaborations

He collaborates with talented individuals such as Rishi Sharma and Santiago Appiani, contributing to a dynamic team focused on groundbreaking research and development.

Conclusion

Jeffrey L. Cleland's work exemplifies the impact of innovative thinking in medicine. His patents and ongoing research are crucial for developing effective treatments for complex health issues.